Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 6/20 | 0.51 |
| ▸ | MMP9 | P14780 | 6/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | CASP3 | P42574 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.49 |
| ▸ | MMP3 | P08254 | 1/20 | 0.49 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.49 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1781793 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CA12CA9MMP2MMP9 | |
| SCHEMBL2640824 | 0.90 | HDAC7 (0.53) | ALDH1A1CA12CA9MMP2MMP9 | |
| SCHEMBL2640823 | 0.90 | HDAC7 (0.53) | ALDH1A1CA12CA9MMP2MMP9 | |
| SCHEMBL11686163 | 0.89 | HDAC1 (0.59) | ALDH1A1CA12CA9MMP2MMP9 | |
| SCHEMBL7080833 | 0.86 | ALDH1A1 (0.58) | ALDH1A1CA12CA9MMP2MMP9 | |
| SCHEMBL12605262 | 0.85 | ALDH1A1 (0.54) | ALDH1A1CA12CA9MMP2MMP9 | |
| SCHEMBL30307799 | 0.83 | ALDH1A1 (0.52) | ALDH1A1CA12CA9MMP2MMP9 | |
| SCHEMBL8897056 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CA12CA9MMP2MMP9 | |
| SCHEMBL11656910 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CA12CA9MMP2MMP9 | |
| SCHEMBL8898810 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CA12CA9MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060002-A | High-selectivity synthesis method of amikacin sulfate | 山东安信制药有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-118679637-A | Separator for electrochemical device, and electronic device | 宁德新能源科技有限公司 | 2024-09-20 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| WO-2023184173-A1 | SEPARATOR FOR ELECTROCHEMICAL DEVICE, ELECTROCHEMICAL DEVICE, AND ELECTRONIC DEVICE | 宁德新能源科技有限公司 | 2023-10-05 | — | — | WO | claimed |
| WO-2023159610-A1 | SEPARATOR FOR ELECTROCHEMICAL DEVICE, ELECTROCHEMICAL DEVICE, AND ELECTRIC APPARATUS | 宁德新能源科技有限公司 | 2023-08-31 | — | — | WO | claimed |
| CN-115956324-A | Separator for electrochemical device, and electricity-using equipment | 宁德新能源科技有限公司 | 2023-04-11 | — | — | CN | claimed |
| CN-111138505-B | Preparation method of amikacin | 山东安信制药有限公司 | 2021-10-08 | — | — | CN | claimed |
| CN-110642907-B | Synthesis method of prazolamide or salt thereof | 上海博璞诺科技发展有限公司 | 2020-11-06 | — | — | CN | claimed |
| CN-108976267-B | Method for synthesizing amikacin | 北大方正集团有限公司 | 2020-10-13 | — | — | CN | claimed |
| CN-110642907-A | Synthesis method of prazolamide or salt thereof | 上海博璞诺科技发展有限公司 | 2020-01-03 | — | — | CN | claimed |
| CN-110577558-A | Preparation method of amikacin | 南京济群医药科技股份有限公司 | 2019-12-17 | — | — | CN | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | Indiana University Research and Technology Corpora tion (US) | 2016-06-23 | — | — | US | claimed |
| US-9217012-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-12-22 | — | — | US | claimed |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) | 2012-04-12 | — | — | US | claimed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | claimed |
| JP-1275594-A | — | — | None | — | — | JP | disclosed |
| US-4001208-A | DERIVATIVE OF AN AMINOGLYCOSIDIC ANTIBIOTIC | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYO KAI (JA) | 1977-01-04 | — | — | US | disclosed |
| US-3974137-A | ANTIBACTERIAL, ALDEHYDE BLOCKING AGENT | BRISTOL-MYERS COMPANY (US) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | ALDH1A1 3087/4885CA12 4479/4885CA9 3829/4885 |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | ALDH1A1 3087/4885CA12 4479/4885CA9 3829/4885 |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | ALDH1A1 3087/4885CA12 4479/4885CA9 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.